Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Insurance
    • Aditya Birla Health...

    Aditya Birla Health Insurance looks at 8-10 percent market share

    Written by supriya kashyap kashyap Published On 2016-12-11T10:34:34+05:30  |  Updated On 11 Dec 2016 10:34 AM IST
    Aditya Birla Health Insurance looks at 8-10 percent market share

    Kolkata : Aditya Birla Health Insurance, a joint venture between Aditya Birla Group and South Africa based MMI Holdings Ltd., is looking at a 8-10 per cent share in the country's health insurance market in the next four to five years, a top official of the company said.


    At present, the health insurance market size for the health insurance vertical is Rs 27,000 crore.


    "We aim at expanding the Rs 27,000 crore category. We would be happy if we will be able to get a 8-10 per cent market share of the health insurance segment in the 4-5 years' time," said company's CEO Mayank Bathwal.


    He also said the insurer would like to be among top five health insurance players in the next five years.


    The group holds 51 per cent stake in the new venture while South African financial services company has the balance 49 per cent stake.


    The new firm has injected Rs 250 crore capital, he said.


    The new entrant in the health insurance will have multi-channel distribution model across agency, broking, bancassurance, direct marketing, online channel and more. The agency channel will start with nine branches in seven tier-I cities. "We would like to expand to 100 cities in 2-3 years," Bathwal said.


    The health insurance penetration in India is very low. "Less than three per cent of retail population has some form of health cover. In the US health insurance penetration is 77 per cent while in China, the same is 35 per cent," said Aditya Birla Financial Services Ltd's Chief Marketing Officer Ajay Kakar.

    Aditya BirlaAditya Birla Health InsuranceAjay Kakarhealth insuranceinsuranceMayank Bathwal
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok